Semaglutide drug compounders have already sued the FDA for this decision, saying it was a reckless and arbitrary decision
Separately, the Medicare GLP-1 Bridge (launching July 1, 2026, running through December 31, 2027) provides weight-loss access to Wegovy at a fixed $50 per month copay outside the Part D benefit meaning the $50 does not count toward the deductible, TrOOP, or the $2,100 cap, and Extra Help cannot be applied
I'm thrilled to say that I've conquered my first goal, shedding an incredible 50 pounds! With a team of medical experts, were here to give you the best experience for personalized weight loss with comprehensive diagnostics and access to science-backed therapies and clinical guidance
These strategies not only illustrate the depth and breadth of pharmaceutical research but also signify the frontier of future medical innovations